Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient
- PMID: 15302196
- DOI: 10.1016/S0140-6736(04)16811-6
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient
Abstract
We report a case of preclinical variant Creutzfeldt-Jakob disease (vCJD) in a patient who died from a non-neurological disorder 5 years after receiving a blood transfusion from a donor who subsequently developed vCJD. Protease-resistant prion protein (PrP(res)) was detected by western blot, paraffin-embedded tissue blot, and immunohistochemistry in the spleen, but not in the brain. Immunohistochemistry for prion protein was also positive in a cervical lymph node. The patient was a heterozygote at codon 129 of PRNP, suggesting that susceptibility to vCJD infection is not confined to the methionine homozygous PRNP genotype. These findings have major implications for future estimates and surveillance of vCJD in the UK.
Comment in
-
Transfusion transmission of vCJD: a crisis avoided?Lancet. 2004 Aug 7-13;364(9433):477-9. doi: 10.1016/S0140-6736(04)16820-7. Lancet. 2004. PMID: 15302172 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
